期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

结核分枝杆菌ClpP1重组蛋白的特性探讨及初步应用 被引量：1

The characteristics and preliminary application of ClpP1 recombinant protein of Mycobacterium tuberculosis
下载PDF
导出
摘要 目的用纯化结核分枝杆菌(Mycobacterium tuberculosis,M.tb)ClpP1重组蛋白免疫新西兰白兔制备ClpP1多克隆抗体并检测其效价,间接ELISA法分析重组蛋白的抗原性,以初步评价其应用价值。方法通过SDS-PAGE确定ClpP1重组蛋白的主要表达形式,利用纯化包涵体方式对重组蛋白进行纯化;将纯化蛋白免疫新西兰白兔制备ClpP1多克隆抗体并检测其效价;再分别以纯化蛋白为抗原,制备抗体为一抗,间接ELISA法检测临床诊断结核病患者血清中抗M.tb抗体和M.tb抗原。结果 SDSPAGE显示ClpP1重组蛋白主要以包涵体表达形式存在,将纯化蛋白免疫新西兰白兔4次,取血测抗体效价为1∶64 000;Western blot结果显示制备抗体可较好的与ClpP1蛋白特异性结合;间接ELISA法结果表明,以重组蛋白为抗原测患者血清中抗M.tb抗体和以制备抗体为一抗测血清中的M.tb抗原的2实验组分别与对照组相比均具有显著性差异。结论制备了具有免疫原性的M.tb ClpP1重组蛋白及效价较高的多克隆抗体,并得出ClpP1多克隆抗体具有较好的免疫反应性,为进一步研究ClpP1重组蛋白的特性及其应用奠定了基础。 The genome of Mycobacterium tuberculosis （M. tb）, the main causative agent for tuberculosis, encodes proteases including proteasome and Clp proteases. In this study, we aimed to prepare Clp proteases 1 （ClpP1） polyclonal antibody, analyze its antigenicity by indirect ELISA, and explore its preliminary application. Firstly, ClpP1 protein was purified and used to immunize rabbits for 4 times for preparing ClpP1 polyclonal antibody, and titer of the antibody was detected as 1：64 000. Western blot test showed that the polyclonal antibody could specifically bind with ClpP1 recombinant protein and ClpP1 protein of acilli Calmette-Guerin （BCG）. Indirect ELISA revealed the ClpP1 recombinant protein high immunogenicity and could strongly react with the prepared ClpP1 polyclonal antibody in sera of tuberculosis. All the result indicated that immunogenic ClpP1 recombinant protein and polyclonal antibody with high titer are successfully prepared, which would lay a foundation for further study on the characteristics and application of ClpP1 recombinant protein.
作者 张春燕 杨春 李岱容 穆柳青 樊宇 何永林
机构地区 重庆医科大学病原生物学教研室分子医学与肿瘤研究中心 重庆医科大学附属第一医院呼吸内科
出处 《免疫学杂志》 CAS CSCD 北大核心 2014年第4期306-309,313,共5页 Immunological Journal
基金 国家自然科学基金青年基金项目(81101216)
关键词 结核分枝杆菌 ClpP1重组蛋白 多克隆抗体 Mycobacterium tuberculosis ClpP1 protein Polyclonal antibody
分类号 R378.911 [医药卫生—病原生物学]
  • 相关文献

参考文献17

  • 1Word Health Organization. WHO GlohaI Task Force on TB Impact Measurement-information leaflet[EB/OL]. (2013-4- 15 ) [2013 - 10 -20].http://www.who.int/th/publieations/ faetsheet_th_impactnleasurement.pdf?ua= 1.
  • 2Rawlings ND, Barrett AJ, Bateman A. MEROPS: the database of proteolytie Enzymes, their substrates anti inhibitors[J]. Nucleic Acids Res. 2013, 41 (1): 503-509.
  • 3Porankiewicz J.Wang J,Clarke AK. New insights into the ATP-dependent Clp protease: Escherichia coli and beyond[J]. Mol Microbiol, 1999, 32(3): 449-458.
  • 4Chastanet A, Prudhomme M, Claverys JP, et al. Regulation of Streptococcus pneumoniae clp genes and their role in competence development and stress survival [J]. J Bacteriol,2001, 183(24): 7295-7307.
  • 5Ollinger J, O'Malley T, Edward A, et al. Validation of the essential ClpP prot-ease in Mycob~wterium Tuberculosis as a novel drug target[J]. J Baeteriol, 2012, 194(3): 663-668.
  • 6Raju RM,Unnikrishnan M,Rubin DH. Mycobacterium tuberculosi.s ClpP1 and ClpP2 function together in protein degradation and are required fnr viability in vitro and during infection[J]. PloS Pathog, 2012, 8(2): 100-109.
  • 7Akopian T, Kandror O. Raju RM, et al. The active ClpP protease from M. tuberculosis is a complex eomposed of a heptamerie ClpP1 and a ClpP2 ring[J]. EMBO J, 2012, 31(6): 1529-1541.
  • 8Carroll P, Faray Kele MC, Parish T. Identifying vulnerable pathways in Myobacterium tuberculosis by using a knockdown approaeh [J]. Appl Environ Microbiol, 2011, 77(14): 5040-5043.
  • 9杨雅,刘耀,李頔,吕军,陈剑鸿,孙凤军,田志强,夏培元.CLP-19预处理RAW264.7细胞对炎性因子的调节作用初探[J].免疫学杂志,2013,29(3):185-189. 被引量：2
  • 10Zhao QJ, Xie JP. Mycobacterium Tuberculosis proteases and implications for new antibiotics against tuberculosis [J]. Crit Rev Eukaryot Gene Expr, 2011, 21(4): 347-361.

二级参考文献24

  • 1霍康,谢鹏,徐鸣明,张晓东,展群岭,杨德雨,胡永波.博尔纳病毒核蛋白的原核表达、纯化及鉴定[J].免疫学杂志,2009,25(4):385-388. 被引量：8
  • 2Yao-Chi Chung,Jen-Huang Huang,Chia-Wei Lai,Heng-Chun Sheng,Shin-Ru Shih,Mei-Shang Ho,Yu-Chen Hu.Expression,purification and characterization of enterovirus-71 virus-like particles[J].World Journal of Gastroenterology,2006,12(6):921-927. 被引量：43
  • 3Ren JD, Gu JS, Gao HF, et al. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo [J]. Int Immunopharmacol, 2008, 8(6): 775-781.
  • 4Ren JD, Gao H, Tang M, et al. Lipopolysaccharide (LPS) detoxification of analogue peptides derived from limulus anti-LPS factor[J]. Peptides, 2010, 31(10): 1853-1859.
  • 5Prado Montes de Oca E. Human beta-defensin 1: a restless warrior against allergies, infections and cancer [J]. Int J Biochem Cell Biol, 2010, 42(6): 800-804.
  • 6Park K, Elias PM, Oda Y, et al. Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor- independent pathway[J]. J Biol Chem, 2011,286(39): 34121- 34130.
  • 7Nijnik A, Madera L, Ma S, et al. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment[J]. J Immunol, 2010, 184(5): 2539-2550.
  • 8Van der Does AM, Beekhuizen H, Ravensbergen B, et al. LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature [J]. JImmunol, 2010, 185(3): 1442-1449.
  • 9Yu FS, Cornicelli MD, Kovach MA, et al. Flagellin stimulates protective lung mucosal immunity: role of cathelieidin-related antimicrobial peptide [J]. J Immunol, 2010, 185(2): 1142-1149.
  • 10Gutner M, Chaushu S, Balter D. Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis [J]. Infect Immun, 2009, 77(12): 5558-5563.

共引文献5

同被引文献18

  • 1Warner DF, Koch A, Mizrahi V. Diversity and disease pathogenesis in Mycobacterium tuberculosis[J]. Trends Microbiol, 2015, 23(1): 14-21.
  • 2He F, Hu D, Yu X, et al. An outbreak of Mycobacterium tuberculosis infection associated with acupuncture in a private clinic of Zhejiang Province, China, 2012[J]. Int J Infect Dis, 2014, 29: 287-291.
  • 3Azman AS, Golub JE, Dowdy DW. How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India[J]. BMC Med, 2014, 12: 216.
  • 4Chen M, Kwaku AB, Chen Y, et al. Gender and regional disparities of tuberculosis in Hunan, China[J]. Int J Equity Health, 2014, 13: 32.
  • 5Jia Z, Cheng S, Ma Y, et al. Tuberculosis burden in China: a high prevalence of pulmonary tuberculosis in household contacts with and without symptoms[J]. BMC Infect Dis, 2014, 14: 64.
  • 6Zhao LL, Sun Q, Zeng Cy, et al. Molecular characterisation of extensively drug-resistant Myeobaeterium tuberculosis isolates in China[J]. Int J Antimicrob Agents, 2015, 45(2): 137-143.
  • 7Zimenkov DV, et al. Analysis of genetic determinants of muhidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide mierochip[J]. Mol Biol (Mosk), 2014, 48(2): 251-264.
  • 8Shi C, Chen L, Chen Z, et al. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein[J]. Vaccine, 2010, 28(32): 5237-5244.
  • 9Cohen Karni D, Xu D, Apone L, et al. The MspJI family of modification-dependent restriction endonucleases for epigenetic studies[J]. Proc Natl Aead Sci USA, 2011, 108(27): 11040-11045.
  • 10Horton JR, Mabuchi MY, Cohen Karni D, et al. Structure and cleavage activity of the tetrameric MspJI DNAmodification-dependent restriction endonuclease[J]. Nucleic Acids Res, 2012, 40(19): 9763-9773.

引证文献1

免疫学杂志
2014年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部